Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
On Demand
Favorite
Facebook
Tweet
Print
Bradford D. Gessner, MD, MPH
Sole Proprietor
EpiVac Consulting
Disclosure(s): Pfizer: Stocks/Bonds (Public Company)
Poster(s):
(P-610) Estimating Risk of Guillain-Barré Syndrome in US Medicare-Enrolled Older Adults Following Medically Attended Respiratory Syncytial Virus Disease: A Self-Controlled Case Series Analysis
Monday, October 20, 2025
12:15 PM - 1:30 PM
US ET
(P-611) Time-Series Model Estimation of Respiratory Syncytial Virus-Attributable Respiratory Hospitalizations and Mortality in Adults in Finland
Monday, October 20, 2025
12:15 PM - 1:30 PM
US ET
(P-642) Attributes of Point-of-Care Nucleic Acid Amplification Tests for Respiratory Syncytial Virus (RSV): Results of a Systematic Literature Review
Monday, October 20, 2025
12:15 PM - 1:30 PM
US ET
(P-1445) Strategies to Promote Adult Vaccination Against Respiratory Pathogens: A Narrative Literature Review
Tuesday, October 21, 2025
12:15 PM - 1:30 PM
US ET
